PharMerica (PMC) Tops Q1 EPS by 3c; Reaffirms Outlook

PharMerica (NYSE: PMC) reported Q1 EPS of $0.30, $0.03 better than the analyst estimate of $0.27. Revenue for the quarter came in at $498.9 million versus the consensus estimate of $493.58 million.

PharMerica reaffirmed FY2012 guidance.

For earnings history and earnings-related data on PharMerica (PMC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• DA Davidson Reiterates Buy Rating on CrowdStrike (CRWD) Ahead of User Conference
• NIO (NIO) PT Lowered to $5 at Bernstein SocGen Group